Revenue Performance: BMNR's revenue heightened by 134.85% YoY and 75.96% QoQ, showcasing a robust upward trajectory amid a competitive environment.
Profitability: Gross profit margin stood at 10.01%, reflecting a slight increase from previous quarters, but operating income registered a significant loss of -$884,018, demonstrating challenges in scaling operations profitably.
Balance Sheet Health: Total assets amount to $7,934,925 with cash and cash equivalents at $797,310, offering a liquidity buffer, albeit a current ratio of 0.333 signals potential short-term liquidity constraints.
Cash Flow: The net cash used in operating activities was -$95,934, indicating struggles to convert revenue into cash, a critical concern for investors.